LEPU BIO-B's stock price soared 14.84% during the intraday session on Thursday, breaking above its half-year moving average.
The significant surge followed the release of the company's annual report, which showed robust financial performance for 2025. Revenue reached 935 million yuan, marking a substantial 154.19% year-on-year increase. Furthermore, the company reported a profit attributable to owners of 261 million yuan, achieving a notable turnaround from a loss to a profit compared to the previous year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments